Joseph Resch

Dr. Joseph Resch


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2023 in Pediatrics in Review
Verified
Journal Article
Closed access
PDF file
ABAshley Bjorklund
Ashley Bjorklund
JRJoseph Resch
Joseph Resch
TSTina Marye Slusher
Tina Marye Slusher
Shock occurs when there is energy failure due to inadequate oxygen/glucose delivery to meet metabolic demands. Shock is a leading cause of death and disability in children worldwide. Types of shock include hypovolemic, cardiogenic, distributive, and obstructive. This review provides an overview of the epidemiology, pathophysiology, and clinical signs and symptoms of each of these types of shock, followed by a discussion of advancements in diagnostic tests and tools and management/treatment principles for different categories of shock.

19 October 2023 in Journal of Liver Transplantation
Verified
Journal Article
Open access
MMMercedes Martinez
Mercedes Martinez
EKElise Kang
Elise Kang
FBFernando Beltramo
Fernando Beltramo
MNMichael Nares
Michael Nares
AJAsumthia Jeyapalan
Asumthia Jeyapalan
DMDanielle Maue
Danielle Maue
Vascular thromboses (VT) are life-threatening events after pediatric liver transplantation (LT). Single-center studies have identified risk factors for intra-abdominal VT, but large-scale pediatric studies are lacking. This multicenter retrospective cohort study of isolated pediatric LT recipients assessed pre- and perioperative variables to determine VT risk factors and anticoagulation-associated bleeding complications. Within seven postoperative days, 31/331 (9.37%) patients developed intra-abdominal VT. Open fascia occurred more commonly in patients with VT (51.61 vs 23.33%) and remained the only independent risk factor in multivariable analysis (OR = 2.84, p = 0.012). Patients with VT received more blood products (83.87 vs 50.00%), had significantly higher rates of graft loss (22.58 vs 1.33%), infection (50.00 vs 20.60%), and unplanned return to the operating room (70.97 vs 16.44%) compared to those without VT. The risk of bleeding was similar (p = 0.2) between patients on and off anticoagulation. Prophylactic anticoagulation did not increase bleeding complications in this cohort. The only independent factor associated with VT was open fascia, likely a graft/recipient size mismatch surrogate, supporting the need to improve surgical techniques to prevent VT that may not be modifiable with anticoagulation.

5 January 2023 in Frontiers in Pediatrics
Verified
Journal Article
Open access
JRJoseph Resch
Joseph Resch
RHRachel Hedstrom
Rachel Hedstrom
MSMarie E. Steiner
Marie E. Steiner
SSSameh M. Said
Sameh M. Said
ASArif Somani
Arif Somani
Background: Acute limb ischemia due to microvascular malperfusion may be refractory to initial therapies. Medicinal leech therapy (hirudotherapy) has been attempted in plastic and reconstructive surgery to improve venous congestion in ischemic flaps; however, there are minimal reports related to ischemia secondary to arterial malperfusion. We evaluated a pediatric cohort from an academic intensive care unit with refractory limb ischemia in whom hirudotherapy was attempted to elucidate its use and outcomes.Method: Institutional patient database was queried to identify pediatric patients (<18 years) who received hirudotherapy in the pediatric critical care unit and met inclusion/exclusion criteria. Patient charts were evaluated for indices including demographics, primary disease, coagulative status, vascular access, vasoactive medication dosing, bleeding, leech use, limb and mortality outcomes. Data was evaluated to identify trends or suspected impact on outcomes.Results: Hirudotherapy was used in 7 patients for limb ischemia, 5 with congenital heart disease, and 2 others with viremic shock. Time to leech application following recognition of ischemia averaged 3 days, with duration of use averaging 3.9 days. Five patients discontinued therapy due to bleeding. Mortality rate was 57%, all secondary to multiorgan failure. In 3 surviving patients, 4 of 5 treated limbs resulted in at minimum partial amputation. Vasoactive-inotropic score tended higher prior to leech application, suggesting a vasoconstrictive pathway for arterial malperfusion. No identifiable trends appeared associated with salvaged limb or adverse effects. Blood loss predictably increased with leech application, as did total transfusion requirement.Conclusion: This case series establishes baseline data for use of hirudotherapy in critically ill children with acute limb ischemia caused by arterial malperfusion. Based on this retrospective cohort, we cannot recommend routine use of hirudotherapy for acute limb ischemia from arterial malperfusion in the pediatric intensive care unit. Application of leeches should be aligned with a protocol defining start and stop parameters, standardized leech utilization, and monitoring for adverse outcomes. Future study would benefit from consensus definitions of study outcomes, including perfusion recovery, tissue/limb salvage and bleeding manifestations. Additional prospective studies are needed prior to any standard or systematic recommendations for use.

3 April 2021 in Journal of Cardiac Surgery
Verified
Journal Article
Closed access
PDF file
JRJoseph Resch
Joseph Resch
Sameh M. SaidSameh M. Said
Sameh M. Said
MSMarie E. Steiner
Marie E. Steiner
ASArif Somani
Arif Somani

23 August 2023 in Spine Deformity
Verified
Journal Article
Closed access
PDF file
PSPaul Brian O. Soriano
Paul Brian O. Soriano
JHJason J Haselhuhn
Jason J Haselhuhn
JRJoseph Resch
Joseph Resch
GFGwenyth A. Fischer
Gwenyth A. Fischer
DSDana B. Swanson
Dana B. Swanson
DPDavid W. Polly
David W. Polly

29 June 2023 in Urology Case Reports
Verified
Journal Article
Open access
EKElizabeth Kim
Elizabeth Kim
MPMichael Perlmutter
Michael Perlmutter
HZHaley Zweber
Haley Zweber
JRJoseph Resch
Joseph Resch
Both guaifenesin and dextromethorphan are routinely available nonprescription medications that are also common drugs of abuse amongst young adults. We describe a presentation of guaifenesin and dextromethorphan misuse resulting in acute renal failure due to bilateral nephrolithiasis. The patient underwent placement of bilateral ureteral stents but again formed small renal stones bilaterally. While most renal calculi are not drug-induced, this case highlights the potential for nephrolithiasis after guaifenesin and dextromethorphan ingestion. It suggests that in this combination ingestion multiple mechanisms lead to a prolonged period of nephrolith formation.